You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

January 5, 2026

Vietnam Issues Guidelines on Classification of Medical Devices for Procurement

On December 31, 2025, Vietnam’s Ministry of Health (MOH) issued Circular No. 57/2025/TT-BYT providing guidance on the classification of medical devices according to technical standards and quality requirements (Circular 57), applicable to procurement activities for medical devices in Vietnam.

According to the MOH, the purpose of the classification is to establish a principle-based legal framework and regulations that enable purchasers to easily identify groups of medical devices aligned with their professional requirements and financial capacity.

Some of the key stipulations of Circular 57 are outlined below.

Basis for Determining Technical Standards and Quality

Under Circular 57, the technical standards of medical devices are determined in accordance with Vietnamese laws on standards and technical regulations, through the following means:

  • Certification of conformity with standards in accordance with Vietnamese laws on standards and technical regulations;
  • Results of conformity assessment conducted by an internationally recognized conformity assessment organization or a legally established domestic or foreign conformity assessment organization operating in Vietnam; and
  • Documentation evidencing compliance provided by the medical device owner.

The quality of medical devices is determined based on whether the device has been approved for circulation by the relevant marketing authority of one or more jurisdictions.

Classification of Medical Devices

Circular 57 classifies medical devices into six groups (from Group 1 to Group 6) based on technical standards and quality.

Medical devices subject to classification must simultaneously meet technical standards and quality requirements in accordance with professional specifications and user needs, and must be lawfully marketed in Vietnam.

Medical devices manufactured in Vietnam may participate in all corresponding groups, provided they meet the technical standards required by the user and are lawfully marketed in Vietnam.

Outlook

Circular No. 57 will take effect on February 15, 2026, while the classification requirements will become effective on January 1, 2027.

Holders of medical device registration numbers are advised to proactively prepare documentation demonstrating compliance with technical standards and quality requirements to facilitate the classification process.

RELATED INSIGHTS​ 

December 22, 2014
In association with Lex Mundi, Practical Law Company has published the latest edition in its series of Q&A-style guides to doing business in jurisdictions around the world. The Myanmar chapter, written by Tilleke & Gibbins attorneys, gives an overview of key recent developments affecting doing business in Myanmar as well as an introduction to the legal system; foreign investment, including restrictions, currency regulations and incentives; and business vehicles and their relevant restrictions and liabilities.
December 22, 2014
Practical Law Company, in association with Lex Mundi, has published the latest edition of its Q&A guides to doing business worldwide. The Thailand chapter, authored by Tilleke & Gibbins attorneys, presents an overview of the country’s legal system and the key laws applicable to foreign companies doing business in the Kingdom. In particular, the chapter examines the following main subjects:
August 29, 2014
In response to consumers paying more attention to their dietary nutritional values, the food industry has taken steps to alter its approach to food product labeling. Labels that stipulate nutrient levels in food products (e.g., claiming low fat, high vitamin C, etc.) are now a common sight on food packaging. The Thai Food and Drug Administration (FDA) has, however, set certain criteria that must be met in order to make such nutritional claims and statements.
August 28, 2014
In Thailand, Good Manufacturing Practices (GMP) were first implemented in 1979 for local pharmaceutical manufacturers under the Drug Act 1967 (B.E. 2510). In 1984, the Thai Food and Drug Administration (FDA) campaigned seriously for the pharmaceutical industry, and ultimately managed to update pharmaceutical standards, with the first Guidelines to Good Manufacturing Practices being issued in 1987. Also, as a way to standardize pharmaceutical factories, the Thai FDA began to officially grant GMP Certificates in 1989.